159 related articles for article (PubMed ID: 15047204)
21. Immunoregulation of autoimmunity by natural killer T cells.
Linsen L; Somers V; Stinissen P
Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
[TBL] [Abstract][Full Text] [Related]
22. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
23. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
24. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
[TBL] [Abstract][Full Text] [Related]
25. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
26. Invariant NKT cells and tolerance.
Nowak M; Stein-Streilein J
Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
[TBL] [Abstract][Full Text] [Related]
27. Porcine T lymphocytes and NK cells--an update.
Gerner W; Käser T; Saalmüller A
Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
[TBL] [Abstract][Full Text] [Related]
28. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases.
Oki S; Miyake S
Allergol Int; 2007 Mar; 56(1):7-14. PubMed ID: 17259804
[TBL] [Abstract][Full Text] [Related]
29. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
[TBL] [Abstract][Full Text] [Related]
30. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype.
Montoya CJ; Cataño JC; Ramirez Z; Rugeles MT; Wilson SB; Landay AL
Clin Immunol; 2008 Apr; 127(1):1-6. PubMed ID: 18304877
[TBL] [Abstract][Full Text] [Related]
31. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
Florence WC; Bhat RK; Joyce S
Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
[TBL] [Abstract][Full Text] [Related]
32. Invariant natural killer T cells from rhesus macaque spleen and peripheral blood are phenotypically and functionally distinct populations.
Gansuvd B; Goodwin J; Asiedu CK; Jiang XL; Jargal U; Andrades P; Exley MA; Thomas JM
J Med Primatol; 2008 Feb; 37(1):1-11. PubMed ID: 18199066
[TBL] [Abstract][Full Text] [Related]
33. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
Chen S; Ndhlovu LC; Takahashi T; Takeda K; Ikarashi Y; Kikuchi T; Murata K; Pandolfi PP; Riccardi C; Ono M; Sugamura K; Ishii N
Eur J Immunol; 2008 Aug; 38(8):2229-40. PubMed ID: 18624295
[TBL] [Abstract][Full Text] [Related]
34. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.
Molling JW; Langius JA; Langendijk JA; Leemans CR; Bontkes HJ; van der Vliet HJ; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
J Clin Oncol; 2007 Mar; 25(7):862-8. PubMed ID: 17327607
[TBL] [Abstract][Full Text] [Related]
35. Qualitative and quantitative analysis of subpopulations of cytotoxic effector cells by flow cytometry.
Bonavida B; Braquet M; Lebow LT; Jewett A
J Lipid Mediat Cell Signal; 1994 Feb; 9(1):19-25. PubMed ID: 8032712
[TBL] [Abstract][Full Text] [Related]
36. Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responses.
Hogan AE; Corrigan MA; O'Reilly V; Gaoatswe G; O'Connell J; Doherty DG; Lynch L; O'Shea D
Clin Immunol; 2011 Sep; 140(3):229-35. PubMed ID: 21684213
[TBL] [Abstract][Full Text] [Related]
37. Lower prevalence of circulating invariant natural killer T (iNKT) cells in patients with acute myocardial infarction undergoing primary coronary stenting.
Liu LL; Lu JL; Chao PL; Lin LR; Zhang ZY; Yang TC
Int Immunopharmacol; 2011 Apr; 11(4):480-4. PubMed ID: 21238619
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 6B11 mAb and α-GalCer-loaded CD1d dextramers for detection of iNKT cells by flow cytometry.
Lenart M; Gruca A; Mueck A; Rutkowska-Zapała M; Surman M; Szaflarska A; Kobylarz K; Baran J; Siedlar M
J Immunol Methods; 2017 Jul; 446():1-6. PubMed ID: 28365328
[TBL] [Abstract][Full Text] [Related]
39. Frequency of circulating iNKT cells among Iranian healthy adults.
Fereidouni M; Farid Hosseini R; Jabbari Azad F; Schenkel J; Varasteh A; Mahmoudi M
Cytometry B Clin Cytom; 2010 Jan; 78(1):65-9. PubMed ID: 19714727
[TBL] [Abstract][Full Text] [Related]
40. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
Hermans IF; Silk JD; Yang J; Palmowski MJ; Gileadi U; McCarthy C; Salio M; Ronchese F; Cerundolo V
J Immunol Methods; 2004 Feb; 285(1):25-40. PubMed ID: 14871532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]